Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    15282352 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Ribavirin;   Drug: Interferon alfa-2a;   Drug: Peginterferon alfa-2a
2 Not yet recruiting Efficacy and Tolerability of Grazoprevir and Elbasvir in Peginterferon Alfa Plus Ribavirin Experienced Patients With Chronic Genotype 1 HCV and HIV Co-infection: a Non-randomised, Open-label Clinical Trial
Condition: To Assess the Efficacy of Grazoprevir 100mg and Elbasvir 50mg by Determining the Proportion of Sustained Virological Response 12 Weeks After the End of Therapy
Intervention: Drug: grazoprevir and elbasvir

Study has passed its completion date and status has not been verified in more than two years.